文献速递主动脉疾病外周动脉疾病颈动脉与弓上血管

区域戒烟干预对血管外科患者的影响

Impact of a regional smoking cessation intervention for vascular surgery patients.
PubMed 文献 · J Vasc Surg · 2021-07-21

这项回顾性分析纳入2018至2020年接受血管手术的13,890例患者,评估基于VAPOR试验的三组分戒烟干预效果。吸烟者中44%至少接受一种干预,30天随访戒烟率35%,1年随访戒烟率43%;接受两种干预组分与30天戒烟几率升高相关(OR 1.29,95%CI 1.07-1.55)。

要点

  • 血管手术患者中37%为当前吸烟者,44%吸烟者至少接受一种戒烟干预。
  • 30天随访戒烟率35%,1年随访戒烟率43%。
  • 接受两种干预组分与30天戒烟几率升高相关(OR 1.29,95%CI 1.07-1.55)。

核心结论

  • 在吸烟普遍的血管手术患者队列中,近半数患者术后1年戒烟。
  • 接受两种戒烟干预组分与30天戒烟相关,结果令人鼓舞。
  • 需长期干预以维持更高的1年戒烟率。

研究设计与样本

  • 回顾性分析2018至2020年接受血管手术的患者,共13,890例。
  • 干预基于VAPOR试验,包括简短医生建议、转介电话咨询和尼古丁替代治疗。
  • 主要结局为30天和1年病历回顾和/或患者随访捕获的戒烟。

主要发现

  • 患者平均年龄69.4±10岁,女性4687例(34%),当前吸烟者5158例(37%)。
  • 2245例患者(吸烟者的44%)至少接受一种戒烟干预组分。
  • 4671例有30天随访的患者戒烟率35%,2936例有1年随访的患者戒烟率43%。
  • 30天时,接受两种干预组分与戒烟几率升高相关(OR 1.29,95%CI 1.07-1.55)。
  • 两个时间点,戒烟与急诊手术(30天OR 1.52,95%CI 1.16-1.99;1年OR 1.41,95%CI 1.01-1.97)和开放腹主动脉瘤修复(30天OR 1.71,95%CI 1.20-2.43;1年OR 1.75,95%CI 1.11-2.78)相关。

临床怎么用

  • 血管手术患者应接受基于VAPOR的多组分戒烟干预。
  • 至少提供两种干预组分可能提高30天戒烟率。
  • 需关注长期戒烟维持,尤其术后1年。

局限性

  • 回顾性分析设计。
  • 戒烟结局依赖病历回顾和/或患者随访,可能存在遗漏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Tobacco use is common among vascular surgery patients and negatively impacts outcomes and longevity. In the second quarter of 2018, a statewide vascular quality collaborative launched an initiative across its 35 participating hospitals to promote smoking cessation at the time of surgery. This intervention was based on the Vascular Physician Offer and Report (VAPOR) trial and consisted of 3 components: brief physician-delivered advice, referral to telephone-based counseling, and nicotine replacement therapy. The goal of this study is to evaluate the results of this intervention. METHODS: We performed a retrospective analysis of patients undergoing vascular surgery between 2018 and 2020. Procedures included open abdominal aortic aneurysm repair, endovascular aneurysm repair, open vascular bypass, open thrombectomy, carotid endarterectomy, and carotid stenting. The primary explanatory variables were receipt of tobacco cessation interventions as documented in the medical record. The primary outcome was tobacco cessation, captured during 30-day and 1-year chart review and/or patient follow-up. A multivariable logistic regression model was calculated to estimate the association of covariates with smoking cessation while adjusting for patient and clinical characteristics. RESULTS: A total of 13,890 patients underwent surgery during the study period. The mean age was 69.4 ± 10 years; 4687 patients (34%) were female, and 5158 patients (37%) were current smokers. At least one smoking cessation component was delivered to 2245 patients (44% of smokers). The quit rate was 35% among 4671 patients with 30-day follow-up and 43% among 2936 patients with 1-year follow up. On multivariable regression, at 30 days, receiving two intervention components was associated with 1.29 (95% confidence interval [CI], 1.07-1.55) higher odds of quitting. At both time points, smoking cessation was also associated with undergoing an emergent procedure (30-day odds ratio [OR], 1.52; 95% CI, 1.16-1.99; 1-year OR, 1.41; 95% CI, 1.01-1.97) and undergoing open abdominal aortic aneurysm repair (30-day OR, 1.71; 95% CI, 1.20-2.43; 1-year OR, 1.75; 95% CI, 1.11-2.78). CONCLUSIONS: In a cohort of vascular surgical patients where tobacco use was common, nearly one-half of patients quit smoking 1 year after surgery. Receiving two smoking cessation intervention components was associated with quitting at 30 days. Overall, these results demonstrate encouraging quit rates and identify an opportunity for longer-term intervention to maintain even greater 1-year tobacco cessation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Howard R, Albright J, Osborne N, et al. Impact of a regional smoking cessation intervention for vascular surgery patients. J Vasc Surg. 2021. PMID: 34298118. doi:10.1016/j.jvs.2021.07.103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。